Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Five-Year Results of the Preoperative Accelerated Partial Breast Irradiation (PAPBI) Trial.
Bosma SCJ, Leij F, Vreeswijk S, Maaker M, Wesseling J, Vijver MV, Scholten A, Rivera S, Bourgier C, Auzac G, Foukakis T, Lekberg T, Bongard D, Loo C, Rutgers E, Bartelink H, Elkhuizen PHM. Bosma SCJ, et al. Among authors: bartelink h. Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):958-967. doi: 10.1016/j.ijrobp.2019.12.037. Epub 2020 Jan 25. Int J Radiat Oncol Biol Phys. 2020. PMID: 31987957 Clinical Trial.
Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.
van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Tong D, Winter J, et al. van Dongen JA, et al. Among authors: bartelink h. Eur J Cancer. 1992;28A(4-5):801-5. doi: 10.1016/0959-8049(92)90118-l. Eur J Cancer. 1992. PMID: 1524898 Clinical Trial.
Radiotherapy combined with low-dose cis-diammine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): a randomized three arm phase II study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups.
Schaake-Koning C, Maat B, van Houtte P, van den Bogaert W, Dalesio O, Kirkpatrick A, Bartelink H. Schaake-Koning C, et al. Among authors: bartelink h. Int J Radiat Oncol Biol Phys. 1990 Oct;19(4):967-72. doi: 10.1016/0360-3016(90)90020-k. Int J Radiat Oncol Biol Phys. 1990. PMID: 2170309 Clinical Trial.
The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report.
Begg AC, Hofland I, Moonen L, Bartelink H, Schraub S, Bontemps P, Le Fur R, Van Den Bogaert W, Caspers R, Van Glabbeke M, et al. Begg AC, et al. Among authors: bartelink h. Int J Radiat Oncol Biol Phys. 1990 Dec;19(6):1449-53. doi: 10.1016/0360-3016(90)90357-p. Int J Radiat Oncol Biol Phys. 1990. PMID: 2262369 Clinical Trial.
Dose and volume effects on fibrosis after breast conservation therapy.
Borger JH, Kemperman H, Smitt HS, Hart A, van Dongen J, Lebesque J, Bartelink H. Borger JH, et al. Among authors: bartelink h. Int J Radiat Oncol Biol Phys. 1994 Dec 1;30(5):1073-81. doi: 10.1016/0360-3016(94)90312-3. Int J Radiat Oncol Biol Phys. 1994. PMID: 7961014 Clinical Trial.
319 results